• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于筛选I型子宫内膜癌早期阶段血清生物标志物的靶向蛋白质组学方法。

A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer.

作者信息

Ura Blendi, Capaci Valeria, Aloisio Michelangelo, Di Lorenzo Giovanni, Romano Federico, Ricci Giuseppe, Monasta Lorenzo

机构信息

Institute for Maternal and Child Health-IRCCS Burlo Garofolo, 34137 Trieste, Italy.

Department of Medicine, Surgery and Health Sciences, University of Trieste, 34129 Trieste, Italy.

出版信息

Biomedicines. 2022 Aug 2;10(8):1857. doi: 10.3390/biomedicines10081857.

DOI:10.3390/biomedicines10081857
PMID:36009404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9405144/
Abstract

Endometrial cancer (EC) is the most common gynecologic malignancy, and it arises in the inner part of the uterus. Identification of serum biomarkers is essential for diagnosing the disease at an early stage. In this study, we selected 44 healthy controls and 44 type I EC at tumor stage 1, and we used the Immuno-oncology panel and the Target 96 Oncology III panel to simultaneously detect the levels of 92 cancer-related proteins in serum, using a proximity extension assay. By applying this methodology, we identified 20 proteins, associated with the outcome at binary logistic regression, with a -value below 0.01 for the first panel and 24 proteins with a -value below 0.02 for the second one. The final multivariate logistic regression model, combining proteins from the two panels, generated a model with a sensitivity of 97.67% and a specificity of 83.72%. These results support the use of the proposed algorithm after a validation phase.

摘要

子宫内膜癌(EC)是最常见的妇科恶性肿瘤,起源于子宫内部。血清生物标志物的鉴定对于早期诊断该疾病至关重要。在本研究中,我们选取了44名健康对照者和44名肿瘤分期为1期的I型EC患者,使用免疫肿瘤学检测板和Target 96肿瘤学III检测板,通过邻位延伸分析同时检测血清中92种癌症相关蛋白的水平。通过应用这种方法,我们在二元逻辑回归中确定了20种与结果相关的蛋白,第一个检测板的P值低于0.01,第二个检测板有24种P值低于0.02的蛋白。结合两个检测板蛋白的最终多变量逻辑回归模型产生了一个灵敏度为97.67%、特异性为83.72%的模型。这些结果支持在验证阶段后使用所提出的算法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/63c2a2574356/biomedicines-10-01857-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/e8ba53bc5768/biomedicines-10-01857-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/57428180689f/biomedicines-10-01857-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/109479848968/biomedicines-10-01857-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/fa2db1e92800/biomedicines-10-01857-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/1148d872f4fa/biomedicines-10-01857-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/9c27eaf7c21b/biomedicines-10-01857-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/3cc26ba3a4e5/biomedicines-10-01857-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/63c2a2574356/biomedicines-10-01857-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/e8ba53bc5768/biomedicines-10-01857-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/57428180689f/biomedicines-10-01857-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/109479848968/biomedicines-10-01857-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/fa2db1e92800/biomedicines-10-01857-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/1148d872f4fa/biomedicines-10-01857-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/9c27eaf7c21b/biomedicines-10-01857-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/3cc26ba3a4e5/biomedicines-10-01857-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/9405144/63c2a2574356/biomedicines-10-01857-g008.jpg

相似文献

1
A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer.一种用于筛选I型子宫内膜癌早期阶段血清生物标志物的靶向蛋白质组学方法。
Biomedicines. 2022 Aug 2;10(8):1857. doi: 10.3390/biomedicines10081857.
2
A Label-Free Proteomic Approach for the Identification of Biomarkers in the Exosome of Endometrial Cancer Serum.一种用于鉴定子宫内膜癌血清外泌体中生物标志物的无标记蛋白质组学方法。
Cancers (Basel). 2022 Dec 19;14(24):6262. doi: 10.3390/cancers14246262.
3
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer.一种用于鉴定子宫内膜癌和卵巢癌血浆蛋白生物标志物的两步策略。
Clin Proteomics. 2018 Dec 1;15:38. doi: 10.1186/s12014-018-9216-y. eCollection 2018.
4
Targeted proteomics-derived biomarker profile develops a multi-protein classifier in liquid biopsies for early detection of esophageal squamous cell carcinoma from a population-based case-control study.基于人群的病例对照研究中,靶向蛋白质组学衍生的生物标志物谱在液体活检中开发了一种多蛋白分类器,用于早期检测食管鳞状细胞癌。
Biomark Res. 2021 Feb 17;9(1):12. doi: 10.1186/s40364-021-00266-z.
5
Two Dimensional-Difference in Gel Electrophoresis (2D-DIGE) Proteomic Approach for the Identification of Biomarkers in Endometrial Cancer Serum.二维差异凝胶电泳(2D-DIGE)蛋白质组学方法用于鉴定子宫内膜癌血清中的生物标志物
Cancers (Basel). 2021 Jul 20;13(14):3639. doi: 10.3390/cancers13143639.
6
Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.用于子宫内膜癌早期检测的多标志物检测板的开发。催乳素具有较高的诊断效能。
Gynecol Oncol. 2007 Oct;107(1):58-65. doi: 10.1016/j.ygyno.2007.05.041. Epub 2007 Jul 19.
7
Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.通过超高效液相色谱-串联质谱法进行血清脂质组分析或许能够检测出早期子宫内膜癌。
Anal Bioanal Chem. 2023 Apr;415(10):1841-1854. doi: 10.1007/s00216-023-04586-x. Epub 2023 Feb 17.
8
Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis.通过邻近延伸分析从血液和尿液中鉴定新型膀胱癌早期诊断的蛋白质生物标志物。
J Transl Med. 2024 Mar 26;22(1):314. doi: 10.1186/s12967-024-04951-z.
9
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.使用邻近延伸分析的多重蛋白质组学用于鉴定同种异体造血细胞移植中急性移植物抗宿主病的预测性蛋白质生物标志物。
Clin Chem Lab Med. 2023 Jan 20;61(6):1005-1014. doi: 10.1515/cclm-2022-0916. Print 2023 May 25.
10
Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中用于早期检测子宫内膜癌的生物标志物检测面板。
Am J Obstet Gynecol. 2019 Nov;221(5):472.e1-472.e10. doi: 10.1016/j.ajog.2019.06.005. Epub 2019 Jul 4.

引用本文的文献

1
Unlocking the Potential of Liquid Biopsy: A Paradigm Shift in Endometrial Cancer Care.释放液体活检的潜力:子宫内膜癌护理的范式转变。
Diagnostics (Basel). 2025 Jul 30;15(15):1916. doi: 10.3390/diagnostics15151916.
2
Multi-Steroid Profiling and Machine Learning Reveal Androgens as Candidate Biomarkers for Endometrial Cancer Diagnosis: A Case-Control Study.多类固醇分析与机器学习揭示雄激素作为子宫内膜癌诊断的候选生物标志物:一项病例对照研究。
Cancers (Basel). 2025 May 16;17(10):1679. doi: 10.3390/cancers17101679.
3
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer.

本文引用的文献

1
Gel-Based Proteomic Identification of Suprabasin as a Potential New Candidate Biomarker in Endometrial Cancer.基于凝胶的蛋白质组学鉴定超结合珠蛋白作为子宫内膜癌潜在的新候选生物标志物。
Int J Mol Sci. 2022 Feb 14;23(4):2076. doi: 10.3390/ijms23042076.
2
Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis.邻近延伸分析与下一代测序相结合,实现高通量蛋白质组全分析。
Mol Cell Proteomics. 2021;20:100168. doi: 10.1016/j.mcpro.2021.100168. Epub 2021 Oct 27.
3
Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment.
92种蛋白质生物标志物用于子宫内膜癌早期检测的前瞻性评估。
Int J Cancer. 2025 Aug 1;157(3):480-489. doi: 10.1002/ijc.35428. Epub 2025 Apr 3.
4
Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review.基于蛋白质组学、代谢组学和临床数据的子宫内膜癌诊断与预后算法:一项系统综述
Front Oncol. 2023 Apr 6;13:1120178. doi: 10.3389/fonc.2023.1120178. eCollection 2023.
5
Immunological and prognostic significance of tumour necrosis in colorectal cancer.结直肠癌肿瘤坏死的免疫和预后意义。
Br J Cancer. 2023 Jun;128(12):2218-2226. doi: 10.1038/s41416-023-02258-2. Epub 2023 Apr 8.
6
A Label-Free Proteomic Approach for the Identification of Biomarkers in the Exosome of Endometrial Cancer Serum.一种用于鉴定子宫内膜癌血清外泌体中生物标志物的无标记蛋白质组学方法。
Cancers (Basel). 2022 Dec 19;14(24):6262. doi: 10.3390/cancers14246262.
半乳糖凝集素-1 在肿瘤微环境中的免疫抑制作用。
Biomolecules. 2021 Sep 23;11(10):1398. doi: 10.3390/biom11101398.
4
Two Dimensional-Difference in Gel Electrophoresis (2D-DIGE) Proteomic Approach for the Identification of Biomarkers in Endometrial Cancer Serum.二维差异凝胶电泳(2D-DIGE)蛋白质组学方法用于鉴定子宫内膜癌血清中的生物标志物
Cancers (Basel). 2021 Jul 20;13(14):3639. doi: 10.3390/cancers13143639.
5
Cancer statistics for the year 2020: An overview.2020年癌症统计数据概述。
Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588.
6
Roles of matrix metalloproteinase-7 (MMP-7) in cancer.基质金属蛋白酶-7(MMP-7)在癌症中的作用。
Clin Biochem. 2021 Jun;92:9-18. doi: 10.1016/j.clinbiochem.2021.03.003. Epub 2021 Mar 10.
7
Targeted proteomics-derived biomarker profile develops a multi-protein classifier in liquid biopsies for early detection of esophageal squamous cell carcinoma from a population-based case-control study.基于人群的病例对照研究中,靶向蛋白质组学衍生的生物标志物谱在液体活检中开发了一种多蛋白分类器,用于早期检测食管鳞状细胞癌。
Biomark Res. 2021 Feb 17;9(1):12. doi: 10.1186/s40364-021-00266-z.
8
Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples.细胞学检测尿液和阴道样本中子宫内膜癌的诊断准确性。
Nat Commun. 2021 Feb 11;12(1):952. doi: 10.1038/s41467-021-21257-6.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Progesterone induces apoptosis by activation of caspase-8 and calcitriol via activation of caspase-9 pathways in ovarian and endometrial cancer cells in vitro.在体外实验中,孕酮通过激活半胱天冬酶-8诱导卵巢和子宫内膜癌细胞凋亡,而骨化三醇则通过激活半胱天冬酶-9途径诱导细胞凋亡。
Apoptosis. 2021 Apr;26(3-4):184-194. doi: 10.1007/s10495-021-01657-1. Epub 2021 Jan 30.